HNRNPA2B1 and breast carcinoma: Data from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) database presented that there were higher HNRNPA2B1 protein levels in breast cancer, OC, colon cancer, and LUAD (Figure 2(c), P < 0.001).